Anzeige
❌
Mehr »
Donnerstag, 19.11.2026 - Börsentäglich über 12.000 News
Folge dem Geld: Methan im Fokus der COP31!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
OS

WKN: A2PKX1 | ISIN: SE0012570448 | Ticker: 5J6
Tradegate
17.11.26 | 09:10
0,314 Euro
+9,23 % +0,027
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
OSSDSIGN AB Chart 1 Jahr
5-Tage-Chart
OSSDSIGN AB 5-Tage-Chart
RealtimeGeldBriefZeit
0,2840,29118.11.
0,2850,28918.11.

Aktuelle News zur OSSDSIGN Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
03.11.OssDsign AB Q3 Sales Decline5
03.11.OSSDSIGN AB: OssDsign Launches Catalyst Commitment Fusion Warranty Program, Backed by Real-World Evidence of 88.4% Fusion Success in Complex Spine Patients4
03.11.OssDsign AB: OssDsign AB (publ) publishes Q3 2026 interim report154Focused on the levers for sales growth OssDsign AB (publ) announces that the interim report for Q3 2026 is now available as a PDF on the company's website www.ossdsign.com/reports. A PDF version is...
► Artikel lesen
09.09.OSSDSIGN AB: OssDsign surpasses 400 patients in PROPEL spine registry evaluating OssDsign Catalyst2
18.08.Earnings Call: Umsatz von OssDsign stagniert im Q2 2026, Aktie fällt um 6 %10
18.08.OssDsign AB: OssDsign AB (publ) publishes Q2 2026 interim report318Progress: Building the foundation for OssDsign growth OssDsign AB (publ) announces that the interim report for Q2 2026 is now available as a PDF on the company's website www.ossdsign.com/reports. A...
► Artikel lesen
OSSDSIGN Aktie jetzt für 0€ handeln
25.06.OssDsign AB: OssDsign appoints Adam McCollister as new Vice President of Sales299OssDsign Appoints Adam McCollister as Vice President of Sales to Accelerate U.S. Growth of Catalyst Platform Uppsala, Sweden, June 25, 2026 - OssDsign AB (publ.), a leader in next-generation orthobiologic...
► Artikel lesen
10.06.Annual General Meeting held in OssDsign AB2
03.06.OSSDSIGN AB: OssDsign Catalyst outperforms earlier-generation bone graft as a standalone treatment in trauma study11
03.06.OssDsign AB announces updated proposal regarding board fees ahead of the annual general meeting 20262
05.05.OssDsign AB: OssDsign AB (publ) publishes Q1 2026 interim report343Reset: Laying the groundwork for accelerated growth OssDsign AB (publ) announces that the interim report for Q1 2026 is now available as a PDF on the company's website www.ossdsign.com/reports. A PDF...
► Artikel lesen
10.04.OssDsign AB: OssDsign provides pre-release update on Q1 2026 performance447OssDsign AB (publ.) today announces that preliminary revenue for the period January - March, 2026 will be USD 4.035 million or SEK 36.880 million. The company attributes these results to a lack of...
► Artikel lesen
03.02.OssDsign AB: OssDsign AB (publ) publishes year-end report 2025552Strong growth and real-world data set the stage for U.S. market expansion OssDsign AB (publ) announces that the year-end report for 2025 is now available as a PDF on the company's website www.ossdsign.com/reports....
► Artikel lesen
10.12.25OssDsign AB: OssDsign appoints Mark Waugh as new CEO459Uppsala, Sweden, 10th December, 2025 - OssDsign AB (publ.) today announces the appointment of Mark Waugh as CEO, effective 1st January 2026. He most recently served as Senior Vice President - Commercial...
► Artikel lesen
14 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1